3 Top AI Stocks Ready for a Bull Run
May 12, 2024
New home sales in Israel up 21% in Q1
May 12, 2024
Drug shortages are an ongoing fact of life, and many Americans have known the inconvenience of having to wait to ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) saw its share price jump 12.8% yesterday, amid high trading volume, ...
JHVEPhoto/iStock Editorial via Getty Images Shares of Amgen rallied 13% in post-market trading Thursday after the biotech giant issued its ...
Novo Nordisk (NYSE:) reported a robust first quarter with a 24% increase in sales at constant exchange rates (CER), reaching ...
CHICAGO (Reuters) - Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, ...
CR Popular social media platform TikTok is cracking down on most content related to weight loss drugs starting next month, ...
MADRID (Reuters) - Spanish drug maker Grifols, battling a plunge in its share price this year, plans to add independent ...
Bill Oxford CRISPR gene editing technology has been heralded as a revolutionary breakthrough in drug development, enabling scientists to potentially ...
By Bhanvi Satija (Reuters) - Roivant Sciences (NASDAQ:) said on Tuesday its experimental drug to treat non-infectious uveitis helped reduce ...
Teva Pharmaceuticals (NYSE:TEVA) and Viatris (NASDAQ:VTRS) have reportedly won a new chance to challenge patent covering Johnson and Johnson's (NYSE:JNJ) ...